Dante Labs announces ventures into biosimulation and drug discovery, demonstrating the predictive value of the Dante Platform

NEW YORK, April 11, 2022, a global leader in genomic information and precision medicine, announces new genomic driven biosimulation and significant progress made to its drug discovery program, demonstrating

Related Keywords

Andrea Riposati ,Kostenloser Wertpapierhandel ,Laura Dangelo , ,Dante Labs ,Dante ,Labs ,Nnounces ,Dentures ,Biosimulation ,Drug ,Discovery ,Emonstrating ,Predictive ,Value ,Platform ,